Frequency of renal manifestations in patients of Henoch-Schonlein purpura
DOI:
https://doi.org/10.66344/jpad.v31i2.1760Abstract
Background Henoch-Schonlein Purpura (HSP) is a multisystem disorder that has cutaneous, musculoskeletal, gut and kidney manifestations. It is the most common childhood systemic vasculitis and is less frequent in adults. It carries significant morbidity and mortality especially in context of renal outcomes. The purpose of this survey was to determine the frequency of renal manifestations in patients of HSP presenting to a tertiary care center in Pakistan.
Methods The study was conducted in King Edward Medical University (KEMU)/ Mayo Hospital Lahore. 32 patients with clinical HSP were included and detailed history and examination was done followed by laboratory investigations. Patients were followed up for 6 months. All data was recorded in a predesigned proforma.
Results 18 male and 14 female patients in the ratio of 1.3:1 with mean age 26.9+14 years were enrolled. Palpable purpura, abdominal pain and joint pain occurred in 100%, 50% and 41% cases respectively. Anemia (53%) and thrombocytosis (37%) were the most frequent abnormalities on laboratory workup followed by proteinuria (28%). Blood renal parameters were deranged in only 15% and improved on follow-up. More than 90% cases recovered completely without any residual damage.
Conclusion Urinary and blood renal parameters that were deranged among the small percentage of our patients improved over time. HSP in our cohort had very good clinical and renal prognosis.
References
1. Jennette JC, Falk RJ, Bacon PA et al.: 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1-11.
2. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35(3):143–53.
3. Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge. Curr Opin Rheumatol. 2013;25(2):171-8.
4. Saulsbury FT. Henoch-Schonlein purpura. Curr Opin Rheumatol. 2010;22:598-602.
5. Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet. 2007; 369(9566):976-8.
6. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Annals Rheumat Dis. 2006;65(7):936-41.
7. Hetland LE, Susrud KS, Lindahl KH, et al. Henoch-Schonlein purpura: a literature review. Acta Derm Venereol. 2017;97(10): 1160-6.
8. Jauhola O, Ronkainen J, Koskimies O, et al. Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child. 2010;95(11):871-6.
9. Uppal A, Singh R. Henoch schonlein purpura: A review. Int J Appl Dent Sci. 2020;6(2):661-3.
10. Audemard-Verger A, Terrier B, Dechartres A, et al.; French Vasculitis Study Group. Characteristics and management of IgA vasculitis (Henoch-Schonlein) in adults: data from 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol. 2017;69(9):1862-70.
11. Chan H, Tang YL, Lv XH, et al. Risk factors associated with renal involvement in childhood Henoch-Schonlein purpura: a meta-analysis. PLoS One. 2016; 11(11):e0167346.
12. Reamy BV, Servey JT, Williams PM. Henoch-Schonlein Purpura (IgA Vasculitis): Rapid Evidence Review. Am Fam Physician. 2020;102(4):229-33.
13. Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA. Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum. 2002;32(3):149-56.
14. Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine. 2001;80(5):279-90.
15. Calvo-Rio V, Hernandez JL, Ortiz-Sanjuan F, Loricera J, Palmou-Fontana N, Gonzalez-Vela MC, Gonzalez-Lamuno D, Gonzalez-Lopez MA, Armesto S, Blanco R, Gonzalez-Gay MA. Relapses in patients with Henoch–Schonlein purpura: analysis of 417 patients from a single center. Medicine. 2016; 95(28):e4217.
16. Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Schonlein purpura in children. J Clin Rheumatol. 2007;13(1):25-8.
17. Lei WT, Tsai PL, Chu SH, Kao YH, Lin CY, Fang LC, Shyur SD, Lin YW, Wu SI. Incidence and risk factors for recurrent Henoch-Schonlein purpura in children from a 16-year nationwide database. Ped Rheumatol. 2018;16(1):25.
18. Chen P, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schonlein Purpura in children: clinical analysis of 120 cases. Afr Health Sci. 2013;13(1):94-9.
19. Blanco R, Martinez‐Taboada VM, Rodriguez‐Valverde V, Garcia‐Fuentes M, Gonzalez‐Gay MA. Henoch‐Schonlein purpura in adulthood and childhood. Two different expressions of the same syndrome. Arthritis & Rheumatism: Off J Amer Coll Rheumatol. 1997;40(5):859-64.
20. Wang JJ, Xu Y, Liu FF, Wu Y, Samadli S, Wu YF, Luo HH, Zhang DD, Hu P. Association of the infectious triggers with childhood Henoch–Schonlein purpura in Anhui province, China. J Infect Public Health. 2020;13(1):110-7.
21. Calvo-Rio V, Loricera J, Mata C, Martin L, Ortiz-Sanjuan F, Alvarez L, Gonzalez-Vela MC, Gonzalez-Lamuno D, Rueda-Gotor J, Fernandez-Llaca H, Gonzalez-Lopez MA. Henoch-Schonlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine. 2014;93(2):106-13.
22. Karadag SG, Tanatar A, Sonmez HE, Cakmak F, Kıyak A, Yavuz S, Cakan M, Ayaz NA. The clinical spectrum of Henoch–Schonlein purpura in children: a single-center study. Clin Rheumatol. 2019; 38(6):1707-14.
23. Kuret T, Lakota K, Zigon P, Ogric M, Sodin-Semrl S, Cucnik S, Tomsic M, Hocevar A. Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis. Clinic Rheumatol. 2019;38(2):331-8.
24. Gupta V, Aggarwal A, Gupta R, Chandra Chowdhury A, Agarwal V, Lawrence A, Misra R. Differences between adult and pediatric onset Henoch‐Schonlein purpura from North India. Int J Rheumat Dis. 2018; 21(1):292-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Ghazala Butt, Muhammad Anees, Mahwash Rana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
